Zion Market Research Global Spine Biologics Market, 2016–2024 | Page 2

Spine Biologics Market
Global Spine Biologics Market: Overview
Spine biologics is a treatment that is used during the spine fusion surgery for the treatment
of spinal deformities that include spinal cord injuries, trauma, degenerative disc disease,
and tumors. It stimulates the growth of the bone formation through different stages which
include inflammatory, repair, and remodeling. Spine biologics is used in the treatment of
symptomatic deformity to achieve successful arthrodesis. Spine biologics is a minimally
invasive method and it requires less time as compared to that of open surgical procedures.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/spine-
biologics-market
Global Spine Biologics Market: Growth Factors
Major factors that are driving the spine biologics market growth include a rise in the number
of geriatric population, benefits provided by spine biologics is faster recovery, minimal
postoperative time, and ability to activate cellular growth. Spinal disorders are most common
in men and women over 50 years. Spinal injuries can be due to the enlargement of bones &
joints, thickening of the band of the tissue, which supports the spine. This is the key factor
that is fuelling the market growth in the coming years. People who are at the high risk of
spinal deformities need to undergo spinal fusion surgery thus increasing its demand in the
global market. However, higher cost of the bone grafts, hostile reimbursement scenario, and
concerns regarding the bone grafting procedures is expected to hamper the global spine
biologics market growth.